136 related articles for article (PubMed ID: 37535446)
1. Side Groups Convert the α7 Nicotinic Receptor Agonist Ether Quinuclidine into a Type I Positive Allosteric Modulator.
Viscarra F; Chrestia JF; Sanchez Y; Pérez EG; Biggin PC; Bouzat C; Bermudez I; López JJ
ACS Chem Neurosci; 2023 Aug; 14(16):2876-2887. PubMed ID: 37535446
[TBL] [Abstract][Full Text] [Related]
2. Molecular interactions of type I and type II positive allosteric modulators with the human α7 nicotinic acetylcholine receptor: an in silico study.
Targowska-Duda KM; Kaczor AA; Jozwiak K; Arias HR
J Biomol Struct Dyn; 2019 Feb; 37(2):411-439. PubMed ID: 29363414
[TBL] [Abstract][Full Text] [Related]
3. Identification by virtual screening and functional characterisation of novel positive and negative allosteric modulators of the α7 nicotinic acetylcholine receptor.
Smelt CLC; Sanders VR; Newcombe J; Burt RP; Sheppard TD; Topf M; Millar NS
Neuropharmacology; 2018 Sep; 139():194-204. PubMed ID: 30009834
[TBL] [Abstract][Full Text] [Related]
4. Contrasting properties of α7-selective orthosteric and allosteric agonists examined on native nicotinic acetylcholine receptors.
Gill JK; Chatzidaki A; Ursu D; Sher E; Millar NS
PLoS One; 2013; 8(1):e55047. PubMed ID: 23383051
[TBL] [Abstract][Full Text] [Related]
5. Activation of α7 nicotinic receptors by orthosteric and allosteric agonists: influence on single-channel kinetics and conductance.
Pałczyńska MM; Jindrichova M; Gibb AJ; Millar NS
Mol Pharmacol; 2012 Nov; 82(5):910-7. PubMed ID: 22874415
[TBL] [Abstract][Full Text] [Related]
6. Allosteric Agonism of
Gulsevin A; Papke RL; Stokes C; Garai S; Thakur GA; Quadri M; Horenstein NA
Mol Pharmacol; 2019 Jun; 95(6):606-614. PubMed ID: 30944209
[TBL] [Abstract][Full Text] [Related]
7. Competitive binding at a nicotinic receptor transmembrane site of two α7-selective positive allosteric modulators with differing effects on agonist-evoked desensitization.
Collins T; Young GT; Millar NS
Neuropharmacology; 2011 Dec; 61(8):1306-13. PubMed ID: 21820451
[TBL] [Abstract][Full Text] [Related]
8. New quinoline derivatives as nicotinic receptor modulators.
Manetti D; Bellucci C; Dei S; Teodori E; Varani K; Spirova E; Kudryavtsev D; Shelukhina I; Tsetlin V; Romanelli MN
Eur J Med Chem; 2016 Mar; 110():246-58. PubMed ID: 26840365
[TBL] [Abstract][Full Text] [Related]
9. Agonist activation of alpha7 nicotinic acetylcholine receptors via an allosteric transmembrane site.
Gill JK; Savolainen M; Young GT; Zwart R; Sher E; Millar NS
Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5867-72. PubMed ID: 21436053
[TBL] [Abstract][Full Text] [Related]
10. Diversity of Nicotinic Acetylcholine Receptor Positive Allosteric Modulators Revealed by Mutagenesis and a Revised Structural Model.
Newcombe J; Chatzidaki A; Sheppard TD; Topf M; Millar NS
Mol Pharmacol; 2018 Feb; 93(2):128-140. PubMed ID: 29196491
[TBL] [Abstract][Full Text] [Related]
11. Positive allosteric modulators of α7* or β2* nicotinic acetylcholine receptors trigger different kinase pathways in mitochondria.
Uspenska K; Lykhmus O; Arias HR; Pons S; Maskos U; Komisarenko S; Skok M
Int J Biochem Cell Biol; 2018 Jun; 99():226-235. PubMed ID: 29704624
[TBL] [Abstract][Full Text] [Related]
12. Identification of α7 Nicotinic Acetylcholine Receptor Silent Agonists Based on the Spirocyclic Quinuclidine-Δ
Quadri M; Matera C; Silnović A; Pismataro MC; Horenstein NA; Stokes C; Papke RL; Dallanoce C
ChemMedChem; 2017 Aug; 12(16):1335-1348. PubMed ID: 28494140
[TBL] [Abstract][Full Text] [Related]
13. Allosterically Potentiated
Miller DR; Khoshbouei H; Garai S; Cantwell LN; Stokes C; Thakur G; Papke RL
Mol Pharmacol; 2020 Dec; 98(6):695-709. PubMed ID: 33020143
[TBL] [Abstract][Full Text] [Related]
14. Generation of nanobodies acting as silent and positive allosteric modulators of the α7 nicotinic acetylcholine receptor.
Li Q; Nemecz Á; Aymé G; Dejean de la Bâtie G; Prevost MS; Pons S; Barilone N; Baachaoui R; Maskos U; Lafaye P; Corringer PJ
Cell Mol Life Sci; 2023 May; 80(6):164. PubMed ID: 37231269
[TBL] [Abstract][Full Text] [Related]
15. QM-polarized ligand docking accurately predicts the trend in binding affinity of a series of arylmethylene quinuclidine-like derivatives at the α4β2 and α3β4 nicotinic acetylcholine receptors (nAChRs).
Kombo DC; Grinevich VP; Hauser TA; Sidach S; Bencherif M
Bioorg Med Chem Lett; 2013 Sep; 23(17):4842-7. PubMed ID: 23886687
[TBL] [Abstract][Full Text] [Related]
16. Molecular blueprint of allosteric binding sites in a homologue of the agonist-binding domain of the α7 nicotinic acetylcholine receptor.
Spurny R; Debaveye S; Farinha A; Veys K; Vos AM; Gossas T; Atack J; Bertrand S; Bertrand D; Danielson UH; Tresadern G; Ulens C
Proc Natl Acad Sci U S A; 2015 May; 112(19):E2543-52. PubMed ID: 25918415
[TBL] [Abstract][Full Text] [Related]
17. PNU-120596, a positive allosteric modulator of mammalian α7 nicotinic acetylcholine receptor, is a negative modulator of ligand-gated chloride-selective channels of the gastropod Lymnaea stagnalis.
Vulfius CA; Lebedev DS; Kryukova EV; Kudryavtsev DS; Kolbaev SN; Utkin YN; Tsetlin VI
J Neurochem; 2020 Nov; 155(3):274-284. PubMed ID: 32248535
[TBL] [Abstract][Full Text] [Related]
18. Distinct profiles of alpha7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes.
Grønlien JH; Håkerud M; Ween H; Thorin-Hagene K; Briggs CA; Gopalakrishnan M; Malysz J
Mol Pharmacol; 2007 Sep; 72(3):715-24. PubMed ID: 17565004
[TBL] [Abstract][Full Text] [Related]
19. Potentiation and allosteric agonist activation of α7 nicotinic acetylcholine receptors: binding sites and hypotheses.
Sanders VR; Millar NS
Pharmacol Res; 2023 May; 191():106759. PubMed ID: 37023990
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, and Functional Evaluation of a Novel Series of Phosphonate-Functionalized 1,2,3-Triazoles as Positive Allosteric Modulators of α7 Nicotinic Acetylcholine Receptors.
Nielsen BE; Stabile S; Vitale C; Bouzat C
ACS Chem Neurosci; 2020 Sep; 11(17):2688-2704. PubMed ID: 32786318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
